Initiator Pharma A/S

Friday November 1, 2024 the Swedish market closes at 13.00. Denmark and Norway are open as usual.

Initiator Pharma is a biotechnology company. Today, the main focus is to develop drug candidates to be used in treatment of erectile dysfunction in men. The company currently has pharmaceuticals on the market for patients that do not respond on PDE5i pharmaceuticals. Initiator Pharma was created as a spin-off from Saniona and is today based in Åbyhøj.

Quotes for Initiator Pharma A/S

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Claus Elsborg Olesen

Chairperson of the Board

  • Magnus Persson

Board

  • Anette Collin
  • Claus Elsborg Olesen
  • Henrik Moltke
  • Peter Holm
  • Articles of association

    • News

    Show More

    Analysis

    Videos

    Initiator Pharma - Life Science-dagen 2018

    Initiator Pharmas första dag för handel.

    Intervju med CEO Claus Olesen och CMO Ulf Simonsen

    VD Claus Olesen på stora Aktiesparardagen i Lund

    Largest Owners

    Name Capital % Votes % Date
    Linc AB 18,00 18,00 2024-09-30
    Adrigo Asset Management 7,77 7,77 2024-06-30
    Avanza Pension 5,87 5,87 2024-09-26
    Mac Clinical Research Finance LTD 5,46 5,46 2024-02-21
    Claus Elsborg Olesen 2,39 2,39 2024-09-26
    Dan Peters 2,15 2,15 2024-09-26
    Nordnet Pensionsförsäkring 1,71 1,71 2024-09-26
    Annika Espander Jansson 1,68 1,68 2024-06-26
    Mikael Thomsen 1,49 1,49 2024-09-26
    Mats Thorén 1,35 1,35 2024-09-26

    Annual reports, prospectus etc.